Waters Stock (NYSE:WAT)


ForecastRevenueOwnershipFinancialsChartTranscripts

Previous Close

$363.18

52W Range

$275.05 - $414.15

50D Avg

$335.67

200D Avg

$343.31

Market Cap

$23.45B

Avg Vol (3M)

$1.03M

Beta

1.20

Div Yield

-

WAT Company Profile


Waters Corporation is a global leader in specialized measurement, delivering analytical solutions across Asia, the Americas, and Europe. The company operates through two main divisions: Waters and TA. Under its Waters segment, it engineers, manufactures, sells, and provides support for high and ultra-performance liquid chromatography and mass spectrometry (MS) systems. This includes essential consumables like chromatography columns and comprehensive post-warranty service plans. The TA segment focuses on designing, producing, selling, and servicing instruments for thermal analysis, rheometry, and calorimetry. Additionally, Waters develops and supplies sophisticated software that integrates with both its own instruments and those from other manufacturers. The company's advanced MS technology plays a crucial role in various applications, such as drug discovery and development (including clinical trial assessments), analyzing proteins involved in disease processes, ensuring nutritional safety, and conducting environmental testing. Its thermal analysis, rheometry, and calorimetry instruments are vital for assessing the suitability and stability of a wide range of materials, including fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids. These instruments support diverse sectors like industrial manufacturing, consumer goods, healthcare products, and life science research. Waters' extensive client base spans the life sciences, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental sectors, where its products are instrumental in research and development, quality assurance, and general laboratory operations. Established in 1958, Waters Corporation is headquartered in Milford, Massachusetts.

Show More

Industry

Medical - Diagnostics & Research

Sector

Healthcare

Exchange

NYSE

ADR

-

Country

US

Employees

7,600

IPO Date

Nov 17, 1995

Website

WAT Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceDec 25Dec 24Dec 23
Ta Instrument Systems$243.82M$246.20M$252.88M
Chemistry Consumables$631.46M$565.48M$541.47M
Waters Instrument Systems$1.10B$1.03B$1.11B
Waters Service$1.08B$1.01B$951.42M
Ta Service$108.02M$107.76M$101.95M
Product--$1.90B
Service--$1.05B

Fiscal year ends in Dec 25 | Currency in USD

WAT Financial Summary


Dec 25Dec 24Dec 23
Revenue$3.17B$2.96B$2.96B
Operating Income$893.22M$826.35M$817.68M
Net Income$642.63M$637.83M$642.23M
EBITDA$1.10B$1.04B$1.00B
Basic EPS$10.80$10.75$10.87
Diluted EPS$10.76$10.71$10.84

Fiscal year ends in Dec 25 | Currency in USD

Latest Earnings Call Transcripts


Q1 26May 05, 26 | 12:00 AM
Q4 25Feb 09, 26 | 8:30 AM
Q3 25Nov 04, 25 | 8:00 AM

Peer Comparison


TickerCompany
MEDPMedpace Holdings, Inc.
MTDMettler-Toledo International Inc.
INCYIncyte Corporation
ZBHZimmer Biomet Holdings, Inc.
WSTWest Pharmaceutical Services, Inc.
DGXQuest Diagnostics Incorporated
LHLabcorp Holdings Inc.
STESTERIS plc
ILMNIllumina, Inc.
DXCMDexCom, Inc.